Does BOTULINUM TOXIN TYPE A Cause Nephrolithiasis? 209 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 209 reports of Nephrolithiasis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 5.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.
209
Reports of Nephrolithiasis with BOTULINUM TOXIN TYPE A
5.6%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
2
Hospitalizations
How Dangerous Is Nephrolithiasis From BOTULINUM TOXIN TYPE A?
Of the 209 reports, 2 (1.0%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 209 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Nephrolithiasis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE